Rockville, MD-based Sucampo Pharmaceuticals is a global biopharmaceutical company which currently has one marketed product, Amitiza, in its portfolio. Amitiza is approved for chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation (IBS-C) among adult women and opioid-induced constipation (OIC) in patients with chronic non-cancer pain.
Join BioBuzz and sponsor Immunomic Therapeutics to celebrate the move from allergy to oncology application of their proprietary LAMP-Vax™ technology platform. The celebration will be at Bar Louie in the Rockville Town Center on July 27, 2017 from 5 - 7pm. Only a 5 minute walk from the Rockville Metro, please join us for this exciting event.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, is creating the Alexandria Center® for AgTech – RTP — the initial phase of a premier multi-tenant mega campus in Research Triangle Park (RTP) — and is leading the cluster's evolution into a first-in-class AgTech ecosystem at the forefront of newly emerging innovations that address global hunger as it impacts human health. Located at 3054 East Cornwallis Road, which Alexandria recently acquired through an affiliate, the Alexandria Center for AgTech – RTP is adjacent to Alexandria's 6 Davis Drive, and the collective development of the two campuses will form a 1 million square foot-plus mega campus that will support the AgTech sector in its continued, dramatic growth. The first phase of the project is the strategic redevelopment of the Cornwallis site into 175,000 rentable square feet (RSF) of best-in-class office/laboratory and greenhouse facilities and a highly curated amenities center designed to foster innovation, drive productivity and enhance collaboration.
Roche has bought Vienna-based diabetes management platform mySugr for an undisclosed price, the Swiss drugmaker said on Friday, joining a crowd of companies expanding app-based digital health services.
Privately held mySugr offers a logbook for mobile devices to help people track their blood sugar, medications and activity levels. It has been working with Roche since 2014 and previously got funding from Roche's Venture Fund.
Noble Life Sciences (Sykesville, MD) is a rapidly growing contract research organization (CRO) that provides preclinical drug, vaccine and medical device development services, from discovery to GLP-compliant studies for regulatory submissions. The company offers in vitro and in vivo services, including cellular and animal disease model development and experimental design, non-GLP and GLP animal efficacy, toxicity, biodistribution and product release studies in both small and large animals. The company also offers custom antibody production services, research animal and tissue products, and vivarium services.
The representative will be responsible for selling preclinical services to new accounts in order to achieve sales targets, developing new sales in these accounts by monitoring customer's existing projects for successful completion to stated goals, and proposing related and new services as they monitor accounts needs for future CRO services.
The representative is expected to use his/her knowledge of the market and external contacts in companies developing drugs, vaccines, and medical devices to increase sales. The representative will implement sales and marketing strategy and tactics to gain new customers and achieve sales and profit goals in designated geographic territory.
Job Summary: BioFactura is seeking highly motivated applicants with an entrepreneurial spirit for an open position in our biosimilar development programs. We are looking for qualified candidates with a masters or doctoral degree in the life sciences with highly relevant skills and bench experience. The selected candidate will participate in the development and validation of various biosimilar product assays. In this position, the candidate will be responsible for planning, conducting, execution and analysis of experiments using various techniques in protein analysis. Relevant skills include HPLC/U-HPLC (HILIC, RP, SEC, CEX, AEX, affinity), capillary electrophoresis (CE), mass spec, SDS-PAGE, IEF, ELISA, qPCR. Knowledge of protein purification methods and process development/scale-up is a plus. Knowledge of Good Laboratory Practices (GLP) including analytical method qualification/validation and current Good Manufacturing Practices (cGMP) are desired. Experience in the preparation and delivery of oral and written presentations as well as participation in the preparation and submission of grants and/or manuscripts for publication are a plus. Excellent communication skills and the ability to analyze and interpret data, design appropriately controlled experiments independently, and maintain up-to-date laboratory notebooks are a must. This is an excellent opportunity to gain valuable experience with an innovative, small, young Biotech company and build a career in the biopharmaceutical industry. Candidates should feel comfortable working in a high risk/potential high reward environment and able to work overtime and weekends as project needs are determined.
- Masters/Doctoral degree in life sciences
- Hands on experience in protein analytics (3-5 years)• Excellent time management and proven ability to complete projects on time
- Excellent level of initiative and quest for knowledge
- Must be organized and self motivated
- Must have excellent communication and writing skills
- Familiarity with Microsoft Office (Word, Excel and Powerpoint etc.)
- Must love to learn!
Benefits: BioFactura offers a competitive salary and benefit plan including health insurance (medical, dental & prescription) and a retirement plan with employer match.
Contact: Darryl Sampey, Ph.D.President and CEOBioFactura, Inc.8435 Progress Drive, Suite ZFrederick, MD 21701Cell: 240-620-3566Office: email@example.com
FEFA is a government contracting corporation and we have a current opening for a Technology Transfer Support Specialist with CRADA experience. The position is located in Silver Spring, MD. The candidate shall utilize knowledge of technology transfer law and regulatory requirements related to managing life science/medical research to provide advice, guidance, and assistance to Institute staff on issues relating to collaborative and other agreements, inventions, patents, licenses and other technology transfer matters.
The candidate shall also use excellent interpersonal skills in a team environment to prepare, review, and provide assistance with development of intergovernmental and technology transfer agreements to include interagency agreements (IAA), cooperative research and development agreements (CRADA), material transfer agreements (MTA), and nondisclosure agreements (NDA).
The Fellowship in Government provides a unique public policy learning experience, demonstrates the value of science-government interaction and enhances public health science and practical knowledge in government. APHA is looking for candidates with strong public health credentials and an interest in serving as a staff person in the U.S. Congress. The fellowship is based in Washington, D.C. The fellow will have the option of working in the House or Senate on legislative and policy issues such as creating healthy communities, improving health equity, addressing environmental health concerns, population health or the social determinants of health. Much of the work developing public policy happens at the staff level, where these critical issues are not well understood or incorporated into the discussion. The fellow will have the opportunity to make an impact and improve the health of the public.
Defining a great entrepreneurship scene requires a delicate balance. Sure, there has to be a healthy atmosphere of investment and innovation to get people in, but to get them to stay is a whole ‘nother story. Great startup cities need to have a culture, voice and mission. It’s what defines them as unique, a place to go because it’s not only where your skill sets lie, but where you feel like you can help change the world.
Making the cut for a booming community is a culmination of the underdogs, the cities that others overlooked for safe bets. However, when there’s risk, there’s also reward, which is why these cities, in my estimation, are all about to break the mold.
The company plans to use the investment to complete clinical trials for their gene therapy products aimed at choroideremia, retinitis pigmentosa, and macular dystrophy.
Johns Hopkins Applied Physics Lab’s latest space mission: Flying a satellite into an asteroid.
Scientists from the Laurel-based lab recently got the go-ahead from NASA to move forward on design of a spacecraft that could land on an asteroid, and deflect it from a collision course with Earth. The refrigerator-sized spacecraft would be the centerpiece of a mission called Double Asteroid Redirection Test, or DART.
The Biotechnology Innovation Organization (BIO) recently released a report on Bioscience Innovation in the States: Legislation and Job Creation through Public-Private Partnerships. This biennial report provides a good summary of state initiatives serving the industry plus a discussion of new developments and trends by state.
What if you could really understand what someone wanted? What if by asking the right questions and listening to the words another person uses, you could better understand what they wanted – even before they did? What if you could improve all your relationships?
Improved communication and a deeper understanding of motivation is possible. By learning a repeatable framework, based on language choices that expose unconscious motivation, you can experience being 'heard' and better understand others. Dr. Kristin Backstrom, from the Centers for Motivation, will share insights on how language choices express what drives and motivates individuals, helping you learn how to improve teamwork, reduce conflict, and achieve goals.
Y Combinator, Silicon Valley's best known start-up accelerator, thinks it has found a new type of biotechnology start-up.
Life-sciences companies come with a high risk of failure—often, the science behind a proposed invention isn't entirely proven, and turns out not to work. Because of this risk, the traditional way to fund early-stage life sciences companies is for a landmark East Coast investor, such as Third Rock or Flagship, to take a huge equity stake in the business and replace the founder with a seasoned executive. In exchange, it pumps tens of millions of dollars into the company over many years. It often takes more than a decade to generate a return.
The next NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Omnibus funding opportunity deadline is September 5, 2017. The National Heart, Lung, and Blood Institute (NHLBI) welcomes all investigator-initiated projects within their mission through these funding opportunities:
Along with training artists, MICA is showing more desire to educate students in creating business opportunities with their work.
That’s evident in community facing events, as the Station North arts college now runs a startup competition, and is helping students get space at OpenWorks makerspace.
PCI is pleased to announce the publication of the first-ever guide to commercialization at Penn. We created the Commercialization Guide so that faculty and external partners would have an easy and accessible reference to guide them in pursuing commercial partnerships and entrepreneurial activities at Penn. The guide provides both comprehensive and detailed information around working with PCI on all kinds of commercialization activities and it also covers key topics such as: Penn’s Patent Policy, creating a startup at Penn, the process for patenting intellectual property, disclosing conflicts of interest and other important topics for engaging in commercialization.